Medicine
Repatha 140 mg/1 mL injection
Repatha 140 mg/1 mL injection is a prescription medicine containing Evolocumab for subcutaneous use, marketed by Amgen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to…
Key facts
- Active ingredient (INN)
- Evolocumab
- Brand
- Repatha
- Strength
- 140 mg/1 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 syringe of 1 mL, 2 syringes of 1 mL and 4 more
- Marketing authorisation holder
- Amgen
- Manufacturer
- Amgen
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze. REPATHA prefilled single-dose pen, prefilled single-dose SureClick ® autoinjector, or prefilled single-dose syringe may also be kept at room temperature at 68°F to 77°F (20°C to 25°C) in the original carton for 30 days. Do not shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C10AX13 Evolocumab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 October 2018
- Identifiers
- RxCUI 1665895, 1665900, 1665904 +1DailyMed set ID cd61e902-166d-4aa6-9f3c-a18c1008d07eNDC 72511-750, 72511-501, 72511-143 +2Application BLA125522
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe in 1 carton / 1 mL in 1 syringe | 72511-143-01 | Amgen | 13 July 2026 |
| 1 syringe in 1 carton / 1 mL in 1 syringe | 72511-143-02 | Amgen | 13 July 2026 |
| 1 syringe in 1 carton / 1 mL in 1 syringe | 72511-393-01 | Amgen | 24 November 2024 |
| 2 syringe in 1 carton / 1 mL in 1 syringe | 72511-393-02 | Amgen | 24 November 2024 |
| 1 syringe in 1 carton / 1 mL in 1 syringe | 72511-501-01 | Amgen | 24 November 2024 |
| 1 syringe in 1 carton / 1 mL in 1 syringe | 72511-750-01 | Amgen | 9 October 2018 |
| 2 syringe in 1 carton / 1 mL in 1 syringe | 72511-760-02 | Amgen | 9 October 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Evolocumab is a PCSK9 inhibitor. It is available as injection for subcutaneous use. MedsAcross supplies Evolocumab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EvolocumabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- REPATHA prescribing information (Amgen) · U.S. National Library of Medicine, DailyMed
- Repatha: European public assessment report (EPAR) · European Medicines Agency
Need Repatha 140 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.